Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancers|August 7, 2021
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin MelanomasMaximilian Gassenmaier, Matthias Hahn, Gisela Metzler, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2017
Safety of shortened infusion times for combined ipilimumab and nivolumabMaximilian Gassenmaier, Hans-Peter Lipp, Alexander Scheu, et al.
The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2022
Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-upMaximilian Gassenmaier, Narges Soltanpour, Laura Held, et al.
Journal of the American Academy of Dermatology|February 1, 2019
Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, et al.
The American Journal of Pathology|July 18, 2020
Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic TumorsMaximilian Gassenmaier, Maximilian Rentschler, Birgit Fehrenbacher, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2020
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitorsJohanna Winter, Max M Lenders, Maximilian Gassenmaier, et al.
Journal of the American Academy of Dermatology|December 3, 2023
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort studyNikolaus B Wagner, Sarah M Knierim, Felix Luttermann, et al.
The American Journal of Surgical Pathology|March 12, 2025
Cutaneous Hemangioma With Epithelioid Features Harboring TPM3/4::ALK Fusions : A Distinct Entity or a Molecular Variant of Epithelioid Hemangioma?Carina A Dehner, George Jour, Maximilian Gassenmaier, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort studyNikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.
Pageof 3